Group 1 - Huafeng Co., Ltd. announced a stock suspension due to a potential change in control after signing a share transfer intention agreement [1] - Keshida plans to reduce its shareholding by up to 424,000 shares, representing 0.07% of its total share capital [1] - Jinqilin intends to distribute a cash dividend of 0.10 yuan per share, totaling 19.61 million yuan [1] Group 2 - Rejingshi Biotech has repurchased 904,100 shares, accounting for 0.98% of its total share capital, with a total expenditure of 150 million yuan [2] - Yishitong has repurchased 1,236,500 shares, representing 0.619% of its total share capital, with a total expenditure of approximately 33.49 million yuan [2] Group 3 - Hanjia Design announced the release of a detention on its subsidiary's chairman, allowing him to resume duties [4] - Qingmu Technology plans to acquire 65.83% of Vitalis Pharma AS for 300 million Norwegian Krone (approximately 212 million yuan) [4] - Anda Intelligent's shareholder plans to reduce its stake by up to 2.74% [4] Group 4 - Wansheng Intelligent is a candidate for a project with a pre-bid amount of approximately 42.99 million yuan, representing 4.56% of its audited revenue for 2024 [4] - Yipin Hong received a drug registration certificate for a medication used to treat Alzheimer's symptoms [4] Group 5 - *ST Sansheng received a total of 254 million yuan from restructuring investors [4] - Haichuang Pharmaceutical received approval for clinical trials of HP518 tablets for advanced prostate cancer treatment [4] Group 6 - Ningbo Huaxiang's subsidiary plans to invest 5 million yuan in a venture capital fund focusing on intelligent industries [4] - Petty Co. plans to repurchase shares worth 50 to 70 million yuan [4] Group 7 - Tongji Technology's subsidiary won a construction project with a bid price of 866 million yuan [4] - Prolo Pharmaceutical received a drug registration certificate for a generic drug [4] Group 8 - Jingyan Technology plans to use up to 1.6 billion yuan of idle funds for financial management [4] - Furan De received government subsidies totaling 34.65 million yuan [4] Group 9 - David Medical's subsidiary's medical device registration has been accepted [4] - Jusaylong plans to increase its subsidiary's capital by 170 million yuan through debt-to-equity conversion [4] Group 10 - Heng Rui Pharmaceutical's application for a drug license has been accepted by the National Medical Products Administration [4] - Lege Co. plans to increase its stake in the company by 40 to 80 million yuan [4] Group 11 - New Beiyang's subsidiary won a project with the Bank of Communications [4] - Jiangxi Changyun plans to publicly transfer land use rights and buildings with a starting price of 7.79 million yuan [4] Group 12 - Shenqi Pharmaceutical's subsidiary has paid approximately 16.67 million yuan in tax and penalties [4] - Panjiang Co. plans to invest 1.334 billion yuan in a power plant project [4] Group 13 - Fashilong's vice president resigned for personal reasons [4] - Chunxue Food received government subsidies of 3.79 million yuan [4] Group 14 - China Galaxy completed the repayment of a short-term financing bond totaling 3.025 billion yuan [4] - Jiuzhou Pharmaceutical received approval for a chemical raw material drug [4] Group 15 - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund [4]

（文章来源：证券日报） 证券日报网讯 11月24日晚间，乐歌股份发布公告称，公司于2025年11月21日收到控股股东宁波丽晶电 子集团有限公司（简称"丽晶电子"）通知，基于对公司长期投资价值的认可，以及对公司未来发展前景 的信心，同时为了提升投资者信心，切实维护中小股东利益，结合对公司股票价值的合理和独立判断， 控股股东丽晶电子计划以自有资金与股份增持专项贷款相结合的方式，自本公告披露之日起6个月内通 过集中竞价方式增持公司股份，本次增持金额不低于人民币4，000万元且不超过8，000万元。 ...

格隆汇11月24日丨乐歌股份(300729.SZ)公布，收到控股股东丽晶电子通知，基于对公司长期投资价值 的认可，以及对公司未来发展前景的信心，同时为了提升投资者信心，切实维护中小股东利益，结合对 公司股票价值的合理和独立判断，控股股东丽晶电子计划以自有资金与股份增持专项贷款相结合的方 式，自本公告披露之日起6个月内通过集中竞价方式增持公司股份，本次增持金额不低于人民币4,000万 元且不超过8,000万元。 ...

乐歌股份（300729）(300729.SZ)公告，公司控股股东宁波丽晶电子集团有限公司(简称"丽晶电子")拟在 本公告披露之日起6个月内通过集中竞价方式增持公司股份，本次增持金额不低于4000万元且不超过 8000万元。 ...

格隆汇11月24日丨乐歌股份(300729.SZ)公布，收到控股股东丽晶电子通知，基于对公司长期投资价值 的认可，以及对公司未来发展前景的信心，同时为了提升投资者信心，切实维护中小股东利益，结合对 公司股票价值的合理和独立判断，控股股东丽晶电子计划以自有资金与股份增持专项贷款相结合的方 式，自本公告披露之日起6个月内通过集中竞价方式增持公司股份，本次增持金额不低于人民币4,000万 元且不超过8,000万元。 ...

智通财经APP讯，乐歌股份(300729.SZ)公告，公司控股股东宁波丽晶电子集团有限公司(简称"丽晶电 子")拟在本公告披露之日起6个月内通过集中竞价方式增持公司股份，本次增持金额不低于4000万元且 不超过8000万元。 ...

公司控股股东宁波丽晶电子集团有限公司保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： | 证券代码：300729 | 证券简称：乐歌股份 | 公告编号：2025-082 | | --- | --- | --- | | 债券代码：123072 | 债券简称：乐歌转债 | | 乐歌人体工学科技股份有限公司 关于控股股东增持公司股份计划的公告 1、乐歌人体工学科技股份有限公司（以下简称"公司"）控股股东宁波丽晶电子 集团有限公司（以下简称"丽晶电子"）拟在本公告披露之日起 6 个月内通过集中竞价 方式增持公司股份，本次增持金额不低于人民币 4,000 万元且不超过 8,000 万元。 2、本次增持计划可能存在因资本市场情况发生变化或目前尚无法预判的其他风险 因素导致增持计划的实施无法达到预期的风险，敬请广大投资者注意投资风险。 公司于 2025 年 11 月 21 日收到控股股东丽晶电子通知，基于对公司长期投资价值 的认可，以及对公司未来发展前景的信心，同时为了提升投资者信心，切实 ...

Core Viewpoint - The impact of leasing standards on financial metrics is significantly influenced by the actual leased area, with a notable increase in overseas warehouse space expected by the end of 2024 compared to 2023, leading to a substantial rise in leasing liabilities [1] Group 1: Financial Metrics - By the end of 2024, the overseas warehouse area is projected to reach 662,100 square meters, a more than 100% increase from 289,600 square meters at the end of 2023 [1] - The increase in leased area will result in a significant rise in leasing liabilities for the company [1] Group 2: Profitability Concerns - The initial phase of opening new warehouses is expected to lower overall profit margins due to ramp-up costs [1] - Factors such as FedEx's price increases are anticipated to negatively impact the profitability of overseas warehouses [1] - The strategic losses incurred during the early stages of new business development have contributed to performance falling short of expectations [1]

Core Viewpoint - The company, Lege Co., has achieved steady revenue growth through a dual-driven strategy focusing on overseas warehouse operations and smart home business, despite some fluctuations in profit, with a long-term goal of sustainable development [1] Group 1 - The company emphasizes its commitment to its core business [1] - The dual-driven strategy has led to collaborative development between overseas warehouse operations and smart home business [1] - Revenue has shown steady growth, indicating positive overall performance [1] Group 2 - Profit has experienced fluctuations, but the overall trend remains positive [1] - The company aims for sustainable development as a long-term objective [1]

Core Viewpoint - The company has no plans to establish an overseas warehouse in Taiwan [1] Company Summary - Lege Co., Ltd. (300729.SZ) confirmed on its investor interaction platform that it currently has no plans for building an overseas warehouse in Taiwan [1]